Zenotech Laboratories Ltd

AGM Details

• Date and time: 25 September 2026 at 10:30 IST.
• Mode: Video Conferencing.
• Cut-off date for voting eligibility: 18 September 2026.

Financial results overview

• Revenue from operations: Rs 959.64 lakh; QoQ +8.2%; YoY +11.0%.
• Total income: Rs 1,104.79 lakh; QoQ +5.4%.
• Employee benefits: Rs 491.63 lakh; Depreciation: Rs 190.23 lakh.
• Other expenses: Rs 483.00 lakh; Total expenses: Rs 1,164.86 lakh.
• Loss after tax: Rs 45.55 lakh; basic/diluted EPS: Rs -0.07.
• Total comprehensive loss: Rs 44.38 lakh.
• Single reportable segment: Pharmaceuticals.
• Overseas subsidiaries defunct; no consolidated results.
• Auditor’s review: unaudited standalone; limited review with unmodified conclusion.
• Paid-up equity: Rs 6,103.06 lakh; Reserves: Rs 3,409.05 lakh.
• Other operating income: Rs 101.58 lakh; rentals to Sun Pharma for R&D.
• Year ended 31.03.2026: Total income Rs 4,592.26 lakh; EPS 0.16.
• Board approved the results; quarter ended June 30, 2026.

Dematerialisation processing and listing

• Securities received for dematerialisation in the reporting period were confirmed to depositories.
• The dematerialised securities were listed on the exchanges where the original securities are listed.
• Physical certificates for dematerialisation were mutilated and cancelled after verification.
• Depository name was substituted as registered owner within 15 days.
• Certificate to this effect was sent to depositories and stock exchanges.

Meeting Details

• Board meeting scheduled for July 28, 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve unaudited standalone financial results for quarter ended June 30, 2026.

Other Notes

• Trading window closed from July 1, 2026 to July 30, 2026 (48 hours after results declaration).

Zenotech Laboratories Limited — Trading Window closed from July 01, 2026 till 48 hours after the declaration of Unaudited Financial Results for the quarter ended June 30, 2026